Cargando…
Exacerbation of Autoimmune Bullous Diseases After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Is There Any Association?
BACKGROUND AND AIM: There have been concerns regarding the potential exacerbation of autoimmune bullous diseases (AIBDs) following vaccination against COVID-19 during the pandemic. In the current study, vaccine safety was evaluated in patients with AIBDs. METHODS: In this study, patients with AIBDs...
Autores principales: | Kianfar, Nika, Dasdar, Shayan, Salehi Farid, Ali, Balighi, Kamran, Mahmoudi, Hamidreza, Daneshpazhooh, Maryam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344059/ https://www.ncbi.nlm.nih.gov/pubmed/35928293 http://dx.doi.org/10.3389/fmed.2022.957169 |
Ejemplares similares
-
Pregnancy outcomes in women with pemphigus exposed to rituximab before or during pregnancy
por: Dehghanimahmoudabadi, Azin, et al.
Publicado: (2022) -
Burden of pemphigus vulgaris with a particular focus on women: A review
por: Kianfar, Nika, et al.
Publicado: (2022) -
Characteristics and outcomes of COVID-19 in patients with autoimmune bullous diseases: A retrospective cohort study
por: Mahmoudi, Hamidreza, et al.
Publicado: (2021) -
Assessing quality of life in patients with autoimmune bullous diseases using the Persian version of Treatment of Autoimmune Bullous Disease Quality of Life questionnaire finds similar effects in women as men
por: Behkar, Atefeh, et al.
Publicado: (2022) -
Autoimmune Bullous Disease Quality of Life (ABQoL) questionnaire: Validation of the translated Persian version in pemphigus vulgaris
por: Teimourpour, Amir, et al.
Publicado: (2020)